“The Kenyan government has changed its HIV testing algorithm following the withdrawal of a widely used brand of HIV test [based] on warnings from” the WHO, PlusNews reports. “In November, WHO removed the Standard Diagnostics Bioline HIV 1/2 3.0 Rapid HIV Test Kit from its list of approved rapid test kits with immediate effect … after Bioline failed quality assurance tests,” the news service notes. There is “concern about the impact the recall will have on public confidence in HIV testing, especially as the country pushes for universal access to HIV counseling and testing,” according to the news service (1/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.